Pomegranate extract, a dietary supplement capsule concentrating the fruit's plant compounds, is used in the hope of helping the heart, blood vessels and muscles with age. It is low-risk, but benefits are modest and uneven rather than proven: the most consistent is a small drop in blood pressure, shown mostly with juice. Gains seem to depend on each person's gut bacteria, and product quality is a real concern. (Full Review)

Protocol

Standard POMx regimen

1 g/day

A capsule carrying polyphenols of about 240 mL of juice

Single versus split dosing

Usually once daily up to 1 g

Doses of 2 g or more are split; 3 g/day brought more diarrhea

Pre-exercise use

1,000 mg

About 30 minutes before exercise; 15 days of loading used for cycling

Time to effect

Blood pressure

8–12 weeks

Inflammatory changes appeared on the same timescale

Exercise blood flow

Within 30 minutes

Extract taken about 30 minutes before exercise

Sunburn resistance

12 weeks

At 1,000 mg/day; significant only in urolithin A producers

Benefits

Medium: Blood pressure reduction, rheumatoid arthritis disease activity, endurance performance, memory protection, sunburn resistance

Low: HDL cholesterol and lipid profile, fasting glucose, liver enzymes in fatty liver, menopausal symptoms, knee osteoarthritis symptoms, body weight, carotid atherosclerosis progression, muscle endurance via urolithin A, PSA kinetics in recurrent prostate cancer, strength recovery after eccentric exercise

Speculative: Lower inflammatory and adhesion markers, reduced oxidative stress, cellular aging markers, gut microbiome shifts, colorectal tissue gene expression, fewer oral tooth-decay bacteria

Contraindications

Known pomegranate allergy or lipid-transfer-protein fruit allergy (peach, hazelnut, peanut)

Prior statin-associated rhabdomyolysis or myopathy, while on a statin

Symptomatic low blood pressure (resting systolic below 90 mmHg)

Key Interactions

Tacrolimus

Warfarin

Rosuvastatin and other statins

Theoretical (inferred from mechanism)

ACE inhibitors and ARBs (lisinopril, losartan)

Antiplatelet drugs (aspirin, clopidogrel)

Glucose-lowering drugs (metformin, insulin, sulfonylureas)

Narrow-margin CYP3A4 drugs (carbamazepine)

Blood-pressure-lowering supplements (beetroot nitrate, garlic)

Antiplatelet supplements (fish oil, ginkgo)

Risk & Side Effects

Medium: Dose-related digestive upset

Low: Allergic reactions including anaphylaxis, drug-interaction case reports

Speculative: Additive blood pressure lowering, toxicity from root, stem or peel preparations, blunted training adaptation

Monitoring

Marker	Target	Why
Blood pressure	<120/<80 mmHg	Expected to change; safety on antihypertensives
HDL-C	≥40 mg/dL in men, ≥50 mg/dL in women	Expected modest rise
Fasting glucose	70–99 mg/dL	Expected to change slightly; safety on glucose-lowering drugs
ALT	7–55 U/L (varies by laboratory)	Expected to change in fatty liver; general safety check
INR (warfarin users only)	No established target; prescriber's range	Safety check: a change alters warfarin dosing
Urine urolithin A	No established target; presence (producer) versus absence	Shows conversion to urolithins

Cadence: Home blood pressure twice daily for the first 2 weeks; INR within 7 days of starting or stopping on warfarin; repeat blood tests at 12 weeks, then every 6–12 months while use continues

Qualitative Assessment

Exercise recovery and perceived endurance during familiar sessions
Digestive comfort (stool frequency, nausea, bloating)
Skin response to usual sun exposure (sunburn threshold)
Memory and mental clarity in daily tasks
Any hives, itching or swelling after doses

Pomegranate Extract for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment